(Q84565920)
Statements
Interferon-beta-1a treatment increases CD56bright natural killer cells and CD4+CD25+ Foxp3 expression in subjects with multiple sclerosis (English)
Arthur A Vandenbark
Jianya Huan
Marisa Agotsch
Dorian La Tocha
Susan Goelz
Stefan Lanker
Dennis Bourdette
15 September 2009